Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)

CUSIP: G9TY5A101

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class
Equity / Class A Ordinary Shares, par value $0.0001 per share
Total 13F shares
35,347,572
Total 13F value
$37,112,793
Holder snapshot 6 signals
Share change
-10,384,413
SEC-reported price per share
$1.05
Number of holders
62
Value change
-$12,588,212
Number of buys
34
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
99,155,394

Security key

G9TY5A101

Report period

Q2 2025

Institutions

62

Top holders

10

ZURA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Zura Bio Ltd SEC filings Zura Bio Ltd company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 13F 3/4/5 Lead comparable stake: 4.9% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 4.9%
PFIZER INC 4.6%
ADAR1 Capital Management, LLC 3.2%
Venrock Adviser, LLC 5.1%
SUVRETTA CAPITAL MANAGEMENT, LLC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
13D/G 13F
4.9%
$4,633,204
3,217,503 shares
 $0 31 Dec 2024
PFIZER INC
13D/G 3/4/5 13F
Pfizer Inc. 13-5315170 · 10%+ Owner · Company
13D/G 3/4/5 13F
4.6%
$4,276,832
2,970,022 shares
 $0 31 Dec 2024
ADAR1 Capital Management, LLC
13F 13D/G
Company
13F 13D/G
3.2%
from 13D/G
$3,613,527
2,801,184 shares
 — 31 Mar 2025
Venrock Adviser, LLC
13F
Company
13F
5.1%
$6,479,884
5,023,166 shares
 — 31 Mar 2025
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
13F
4.9%
$6,270,611
4,860,939 shares
 — 31 Mar 2025
Deep Track Capital, LP
13F
Company
13F
3.3%
$4,236,080
3,283,783 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
62
Shares
35,347,572
Rows available
62
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
74
Q2 2025 holders
62
Holder diff
-12
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .